JD Supra14h
FDA Resolves Semaglutide Shortage: Next Steps for Community Pharmacies, Telehealth Companies, and Other Providers
Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...
CNET on MSN6d
Natural Medicine vs. FDA Drugs: Which Should You Use for Your Ailment?
FDA-approved drugs are also often patented and subject to various laws regarding exclusivity for a given manufacturer. At the ...
MyChesCo on MSN4d
FDA Approves Lifesaving Stroke Drug, Xarelto Generics, and Issues Urgent Testosterone Warnings
The U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and ...
Male enhancement capsules recalled for undeclared ingredients, FDA announces
One Source Nutrition, Inc. is voluntarily recalling all of its Vitality male enhancement capsules nationwide after an FDA ...
Healio9d
Two new denosumab biosimilars earn FDA approval
The FDA has approved two new biosimilars of denosumab for all indications of the reference medications Prolia and Xgeva, ...
JD Supra10d
FDA’s Recent Guidance on Accelerated Approval and Implications for Rare Diseases
In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed ...
Monthly Prescribing Reference10d
Denosumab Biosimilars Stoboclo, Osenvelt Get FDA Approval
Safety, pharmacokinetic, and immunogenicity data demonstrated the products were similar. “The approval of Stoboclo and Osenvelt is another step forward in our efforts to deliver cost-effective and ...
Lipocine announces FDA labeling changes for testosterone products
Lipocine (LPCN) announced that the FDA has recently informed sponsors of approved testosterone products about class-wide labeling changes. This ...